Skip to content
2000
image of Aetiology of Fever of Unknown Origin in Two Middle Delta Egyptian Tertiary Health Care Facilities

Abstract

Introduction

Fever of Unknown Origin (FUO) was first defined in 1961 as a temperature greater than 38.3°C on several occasions, lasting for more than 3 weeks, or failure to reach a diagnosis despite one week of inpatient investigation. The time frame has recently been revised to include patients whose illness remains undiagnosed after either a minimum of three outpatient visits or three days of hospitalization. The purpose of this study was to describe the etiology, frequency, and pattern of different causes, particularly infectious causes, and to determine the relative incidence of various causes of FUO in the mid-Delta area of Egypt.

Methods

This retrospective cohort study included all FUO cases registered in the file system over a seven-year period from 2015 to 2022 at Mahala-Kubra Fever Hospital, as well as all admitted FUO cases at the Tropical Medicine and Infectious Diseases Department of Tanta University during 2021 and 2022.

Results

A total of 383 FUO cases were included in the study. Among these, the leading causes of FUO were infections (n = 334, 87.2%), followed by neoplasms (n = 26, 6.8%). Autoimmune and miscellaneous causes ranked third (n = 9, 2.3%), and undiagnosed cases were the least common (n = 5, 1.3%). The two most common infectious causes in this study were urinary tract infection (n = 136, 40.7%) and brucellosis (n = 115, 34.4%). Typhoid fever (n = 29, 8.7%), pneumonia (n = 15, 4.2%), and abscesses (n = 10, 3.0%) were also frequent causes of FUO. Hematological malignancies were the most common malignant causes of FUO, with lymphoma being the most prevalent (n = 10, 38.5%), followed by leukemia (n = 8, 30.8%).

Conclusion

Fever (pyrexia) of unknown origin remains one of the most challenging complexities in medical diagnosis. Infections, particularly Urinary Tract Infections (UTIs) and brucellosis, are the primary causes of FUO in this study. It is also important to recognize that hematological malignancies are a significant cause of FUO.

Loading

Article metrics loading...

/content/journals/raaidd/10.2174/0127724344345490250605065612
2025-06-12
2025-10-20
Loading full text...

Full text loading...

References

  1. PetersdorfR.G. BeesonP.B. Fever of unexplained origin: Report on 100 cases.Medicine196140113010.1097/00005792‑196102000‑0000113734791
    [Google Scholar]
  2. VanderschuerenS. KnockaertD. AdriaenssensT. From prolonged febrile illness to fever of unknown origin: The challenge continues.Arch. Intern. Med.200316391033104110.1001/archinte.163.9.103312742800
    [Google Scholar]
  3. DurackD.T. StreetA.C. Fever of unknown origin-reexamined and redefined.Curr. Clin. Top. Infect. Dis.1991113551[PMID: 1651090
    [Google Scholar]
  4. Bleeker-RoversC.P. VosF.J. de KleijnE.M.H.A. A prospective multicenter study on fever of unknown origin: The yield of a structured diagnostic protocol.Medicine2007861263810.1097/MD.0b013e31802fe85817220753
    [Google Scholar]
  5. HandaR. SinghS. SinghN. WaliJ.P. Fever of unknown origin: A prospective study.Trop. Doct.199626416917010.1177/0049475596026004118937233
    [Google Scholar]
  6. BaicusC. BolosiuH.D. TanasescuC. BaicusA. Fever of unknown origin—predictors of outcome.Eur. J. Intern. Med.200314424925410.1016/S0953‑6205(03)00075‑X12919841
    [Google Scholar]
  7. LiuK.S. ShengW.H. ChenY.C. ChangS.C. HsiehW.C. Fever of unknown origin: A retrospective study of 78 adult patients in Taiwan.J. Microbiol. Immunol. Infect.2003364243247[PMID: 14723252
    [Google Scholar]
  8. Arce-SalinasC.A Morales-Velلzquez JL, Villaseٌor-Ovies P, Muro-Cruz D. Classical fever of unknown origin (FUO): Current causes in Mexico.Rev. Invest. Clin.2005576762769[PMID: 16708901
    [Google Scholar]
  9. SipahiO.R. SenolS. ArsuG. Pooled analysis of 857 published adult fever of unknown origin cases in Turkey between 1990-2006.Med. Sci. Monit.2007137CR318CR322[PMID: 17599026
    [Google Scholar]
  10. HuY. LuH. ZhangY. Fever of unknown origin: Revisit of 142 cases in a tertiary Chinese hospital.Biosci. Trends2008214446[PMID: 20103898
    [Google Scholar]
  11. MoawadM.A. BassilH. ElsherifM. Fever of unknown origin: 98 cases from Saudi Arabia.Ann. Saudi Med.201030428929410.4103/0256‑4947.6525920622346
    [Google Scholar]
  12. KejariwalD. SarkarN. ChakrabortiS.K. AgarwalV. RoyS. Pyrexia of unknown origin: A prospective study of 100 cases.J. Postgrad. Med.2001472104107[PMID: 11832599
    [Google Scholar]
  13. AbdelbakyM.S. MansourH.E. IbrahimS.I. HassanI.A. Prevalence of connective tissue diseases in Egyptian patients presenting with fever of unknown origin.Clin. Med. Insights Arthritis Musculoskelet. Disord.20114334110.4137/CMAMD.S6763
    [Google Scholar]
  14. MahmoodK. AkhtarT. NaeemM. TalibA. HaiderI. Siraj-Us-Salikeen. Fever of unknown origin at a teritiary care teaching hospital in Pakistan.Southeast Asian J. Trop. Med. Public Health2013443503511[PMID: 24050083
    [Google Scholar]
  15. AlaviS.M. NadimiM. ZamaniG.A. Changing pattern of infectious etiology of fever of unknown origin (FUO) in adult patients in Ahvaz, Iran.Caspian J. Intern. Med.201343722726[PMID: 24009968
    [Google Scholar]
  16. BeheraS. SubrahmanyamD.K.S. BajpaiJ. PradhanA. SinghA. Clinical and etiological spectrum of prolonged fever and special reference to HIV patients at a tertiary care centre.Int J Res Med Sci201867224310.18203/2320‑6012.ijrms20182454
    [Google Scholar]
  17. MontasserM.F. AbdelkaderN.A. MontasserI.F. KhoulyA.M.E. Changing the face of fever of unknown origin in Egypt: A single hospital study.Braz. J. Infect. Dis.201519333433510.1016/j.bjid.2015.02.00625911088
    [Google Scholar]
  18. Pan-panZ. JianL. Analysis of etiology of unexplained fever cases reported in Chinese literature in the past 10 years.Elect J Emerg Infect Diseas201834221
    [Google Scholar]
  19. BosilkovskiM. DimzovaM. CvetkovaM. PoposkiK. SpasovskaK. VidinicI. The changing pattern of fever of unknown origin in the Republic of North Macedonia.Rom. J. Intern. Med.201957324825310.2478/rjim‑2019‑000730862765
    [Google Scholar]
  20. ZhouG. ZhouY. ZhongC. Retrospective analysis of 1,641 cases of classic fever of unknown origin.Ann. Transl. Med.202081169010.21037/atm‑20‑387532617310
    [Google Scholar]
  21. AliM. JamesO.C. MohamedA.A. JoachimA. MubiM. OmodiorO. Etiologic agents of fever of unknown origin among patients attending Mnazi Mmoja hospital, Zanzibar.J. Community Health20204551073108010.1007/s10900‑020‑00832‑w32399732
    [Google Scholar]
  22. Vector-borne diseases2024https://www.emro.who.int/egy/programmes/neglected-tropical-diseases.html
    [Google Scholar]
  23. SzymanskiA.M. CliffordH. RonisT. Fever of unknown origin: A retrospective review of pediatric patients from an urban, tertiary care center in Washington, DC.World J. Pediatr.202016217718410.1007/s12519‑019‑00237‑330888665
    [Google Scholar]
  24. KarabelaŞ.N. KartY.K. Fever of unknown origin: Evaluation of 110 classical and HIV-associated cases in the last decade.Hosp. Pract.202250322222710.1080/21548331.2020.177545332520649
    [Google Scholar]
  25. ErdemH. BaymakovaM. AlkanS. Classical fever of unknown origin in 21 countries with different economic development: An international ID-IRI study.Eur. J. Clin. Microbiol. Infect. Dis.202342438739810.1007/s10096‑023‑04561‑536790531
    [Google Scholar]
  26. JiangL. WuH. ZhaoS. ZhangY. SongN. Structured diagnostic scheme clinical experience sharing: A prospective study of 320 cases of fever of unknown origin in a tertiary hospital in North China.BMC Infect. Dis.202323145210.1186/s12879‑023‑08436‑037420165
    [Google Scholar]
  27. HuB. ChenT.M. LiuS.P. Fever of unknown origin (FUO) in children: A single-centre experience from Beijing, China.BMJ Open202212304984010.1136/bmjopen‑2021‑04984035296470
    [Google Scholar]
  28. TornéC.J. BaucellsA.J.M. BlanchF.J. CamellI.H. Fiebre de origen desconocido clلsica: Anلlisis de una cohorte de 87 pacientes segْn la definiciَn con criterio de estudio cualitativo.Med Clيn2021156520621310.1016/j.medcli.2020.03.01432593415
    [Google Scholar]
  29. NguyenT.K. NguyenY.H. NguyenH.T. KhongQ.M. TranN.K. Etiologies of fever of unknown origin in HIV/AIDS patients, Hanoi, Vietnam.BMC Infect. Dis.20222216110.1186/s12879‑022‑07049‑335042469
    [Google Scholar]
  30. SamahaH. Al-RowailyM. KhoudairR.M. AshourH.M. Multicenter study of brucellosis in Egypt.Emerg. Infect. Dis.200814121916191810.3201/eid1412.07145219046520
    [Google Scholar]
  31. ElhaigM.M. WahdanA. Seroprevalence, associated risk factors, and molecular detection of bovine brucellosis in rural areas of Egypt.Comp. Immunol. Microbiol. Infect. Dis.20239510197110.1016/j.cimid.2023.10197136921504
    [Google Scholar]
  32. JacobsM. Imported fever: A survival guide.J. R. Soc. Med.200093312412810.1177/01410768000930030510741311
    [Google Scholar]
  33. BottieauE. ClerinxJ. SchrootenW. Etiology and outcome of fever after a stay in the tropics.Arch. Intern. Med.2006166151642164810.1001/archinte.166.15.1642
    [Google Scholar]
  34. TabakF. MertA. CelikA.D. Fever of unknown origin in Turkey.Infection200331641742010.1007/s15010‑003‑3040‑614735385
    [Google Scholar]
  35. KucukardaliY. OnculO. CavusluS. The spectrum of diseases causing fever of unknown origin in Turkey: A multicenter study.Int. J. Infect. Dis.2008121717910.1016/j.ijid.2007.04.01317629532
    [Google Scholar]
  36. Abdel-GawadM. ZaghloulM.S. Abd-elsalamS. Post-COVID-19 syndrome clinical manifestations: A systematic review.Antiinflamm. Antiallergy Agents Med. Chem.202121211512010.2174/187152302166622032811581835346011
    [Google Scholar]
  37. ElfertA. Abo AliL. SolimanS. IbrahimS. Abd-ElsalamS. Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis.Eur. J. Gastroenterol. Hepatol.201628121450145410.1097/MEG.000000000000072427512927
    [Google Scholar]
  38. Abd-ElsalamS. NoorR.A. BadawiR. Clinical study evaluating the efficacy of ivermectin in COVID‐19 treatment: A randomized controlled study.J. Med. Virol.202193105833583810.1002/jmv.2712234076901
    [Google Scholar]
  39. MohamedA.A. MohamedN. MohamoudS. SARS-CoV-2: The path of prevention and control.Infect. Disord. Drug Targets202121335836210.2174/22123989MTA2gODAe132433010
    [Google Scholar]
  40. QiL. HuangY. LiuZ. Multidimensionally nano-topologized polycaprolactone fibrous membrane anchored with bimetallic peroxide nanodots for microenvironment-switched treatment on infected diabetic wounds.Adv Fiber Mater2024661777179710.1007/s42765‑024‑00447‑z
    [Google Scholar]
  41. LiuW. ZhaoW. XieK. Toughening and responsive contractile shape memory fibrous membrane via water for mechanically active wound dressing.Adv Fiber Mater2024661942195410.1007/s42765‑024‑00463‑z
    [Google Scholar]
/content/journals/raaidd/10.2174/0127724344345490250605065612
Loading
/content/journals/raaidd/10.2174/0127724344345490250605065612
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test